Preoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation
- 1 November 2017
- journal article
- research article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 183, 1-10
- https://doi.org/10.1016/j.ajo.2017.08.013
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Effect of Adjunctive Intravitreal Bevacizumab for Preventing Postvitrectomy Hemorrhage in Proliferative Diabetic RetinopathyOphthalmology, 2011
- PREOPERATIVE INJECTION OF INTRAVITREAL BEVACIZUMAB IN DENSE DIABETIC VITREOUS HEMORRHAGERetina, 2011
- Preoperative Intravitreal Bevacizumab Use as an Adjuvant to Diabetic Vitrectomy: Histopathologic Findings and Clinical ImplicationsOphthalmology, 2011
- A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathyBritish Journal of Ophthalmology, 2011
- Experience with Intravitreal Bevacizumab as a Preoperative Adjunct in 23-G Vitrectomy for Advanced Proliferative Diabetic RetinopathyEuropean Journal of Ophthalmology, 2010
- USE OF INTRAVITREAL BEVACIZUMAB AS A PREOPERATIVE ADJUNCT FOR TRACTIONAL RETINAL DETACHMENT REPAIR IN SEVERE PROLIFERATIVE DIABETIC RETINOPATHYRetina, 2006
- Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24American Journal of Ophthalmology, 1999
- The 14-year incidence of visual loss in a diabetic population,Ophthalmology, 1998
- Complications of Vitreous Surgery for Diabetic RetinopathyOphthalmology, 1983
- Complications of Vitreous Surgery for Diabetic RetinopathyOphthalmology, 1983